Online citations, reference lists, and bibliographies.
← Back to Search

A New Insight Into Encapsulation Process Of A Drug Molecule In The Polymer/surfactant System: A Molecular Simulation Study

Mahboobeh Eslami, S. J. Nikkhah, E. Eslami, S. M. Hashemianzadeh
Published 2020 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Drug delivery plays a substantial role in a more effective treatment of diseases of the central nervous system; therefore, the selection of an appropriate drug carrier system is very important to enhance the effectiveness of drugs. Due to the effect of surfactant on improvement of polymer performance in drug-carrying systems, the present study was devoted to investigating the influence of Polysorbate 80 (Pst80) surfactant on poly( n -butylcyanoacrylate)(PBCA)/Tacrine and Chitosan/Tacrine drug-carrying systems from molecular point of view. Interaction energy, structural characterization, Flory–Huggins interaction parameter, and solvation free energy were investigated for both systems by employing molecular dynamics simulations. According to the interaction energy and Flory–Huggins parameter results, Pst80 can be a more suitable choice for targeted releasing of drug in PBCA/Tacrine system compared with Chitosan/Tacrine system because Pst80 firmly surrounded the drug carrier PBCA and Tacrine. Additionally, the solvation free energy results demonstrated more solubility of PBCA/Pst80/Tacrine in water medium compared with that of Chitosan/Pst80/Tacrine. By consideration on different solvation free energy contributions, it was concluded that using a polymer with both hydrophilic and hydrophobic parts, presence of functional groups with heavy atoms on both polymer and surfactant and similarity in chemical nature of hydrophobic parts of both polymer and surfactant can be useful approaches to reduce the total solvation free energy. Preparation of an appropriate solubility of polymer/drug in water/surfactant medium is essential to enhance drug delivery system efficiency and reduce waste of drug in human body, which can be achieved by designing a drug-carrying system with the minimum solvation free energy. This study confirms the significant role of molecular dynamics simulation for a detailed study of polymer/surfactant/dug systems and clarifies its effective role for designing novel drug delivery systems, along with saving time and cost.
This paper references
10.1016/j.ijpharm.2012.01.051
Hemocompatibility of poly(ɛ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan.
E. A. Bender (2012)
10.1016/j.ejps.2010.05.003
Strategy for effective brain drug delivery.
M. I. Alam (2010)
10.1006/JCPH.1995.1039
Fast parallel algorithms for short-range molecular dynamics
S. Plimpton (1993)
10.1016/0378-5173(91)90219-E
Effect of nonionic surfactants on transdermal drug delivery: I. Polysorbates
M. J. Cappel (1991)
10.18433/J3JC7C
Chitosan mediated targeted drug delivery system: a review.
M. P. Patel (2010)
10.1021/mp900304p
Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram.
K. Pajula (2010)
10.1021/JA00086A030
An ab Initio CFF93 All-Atom Force Field for Polycarbonates
H. Sun (1994)
10.1002/ANDP.19213690304
Die Berechnung optischer und elektrostatischer Gitterpotentiale
P. Ewald (1921)
10.1021/JP980939V
COMPASS: An ab Initio Force-Field Optimized for Condensed-Phase ApplicationsOverview with Details on Alkane and Benzene Compounds
H. Sun (1998)
10.1016/j.bmc.2009.02.043
Nanoparticles in cellular drug delivery.
A. H. Faraji (2009)
10.1016/J.IJPHARM.2005.11.040
Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
K. Gao (2006)
10.1016/0378-5173(95)00025-E
Effects of polysorbate 80 on amiodarone intestinal absorption in the rat
R. Martín-Algarra (1995)
10.1016/j.ejps.2015.11.014
The compatibility of Tacrine molecule with poly(n-butylcyanoacrylate) and Chitosan as efficient carriers for drug delivery: A molecular dynamics study.
M. Eslami (2016)
10.1016/j.ijpharm.2012.05.015
Polysorbate 80 coated poly (ɛ-caprolactone)-poly (ethylene glycol)-poly (ɛ-caprolactone) micelles for paclitaxel delivery.
Y. Wang (2012)
10.1016/j.nano.2009.04.001
Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine.
B. Wilson (2010)
10.1016/0006-8993(95)00023-J
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
J. Kreuter (1995)
10.2174/138920012798356943
Nanotechnologies: a strategy to overcome blood-brain barrier.
G. De Rosa (2012)
10.1134/S0026893308040195
Radius of gyration as an indicator of protein structure compactness
M. Y. Lobanov (2008)
10.1063/1.881812
Understanding molecular simulation: from algorithms to applications
D. Frenkel (1996)
10.1021/JP0352332
Anomalies in the Solubility of Alkanes in Near-Critical Water
C. McCabe (2003)
10.1021/MA00107A006
Ab initio calculations and force field development for computer simulation of polysilanes
H. Sun (1995)
10.1016/0378-5173(89)90266-4
The effect of polysorbate 80 on brain uptake and analgesic effect of D-kyotorphin
T. Sakane (1989)
10.1038/140382b0
Statistical Mechanics:
E. M. (1937)
AdorneMD, Colomé LM et al (2012) with polysorbate 80-lecithin and uncoated or coated with chitosan
EA Bender (2012)
10.2174/092986710791111206
Tacrine derivatives and Alzheimer's disease.
V. Tumiatti (2010)
10.1016/S0140-6736(05)67889-0
Global prevalence of dementia: a Delphi consensus study
C. Ferri (2006)
10.1016/j.ejpb.2008.03.009
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
B. Wilson (2008)
Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
10.1093/nar/gki195
Molecular dynamics simulations and free energy calculations of netropsin and distamycin binding to an AAAAA DNA binding site
J. Dolenc (2005)
12307–12314 Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
C Mccabe (2020)
The compatibi l i ty of Tacrine molecule with poly ( n - butylcyanoacrylate ) and Chitosan as efficient carriers for drug delivery : a molecular dynamics study
M Eslami (2015)
10.1016/j.addr.2011.11.010
Modern methods for delivery of drugs across the blood-brain barrier.
Y. Chen (2012)
10.1016/j.jconrel.2005.09.053
Barriers to carrier mediated drug and gene delivery to brain tumors.
Grace H Huynh (2006)
10.1007/s11095-015-1750-y
Elucidation of Molecular Mechanisms Behind the Self-Assembly Behavior of Chitosan Amphiphilic Derivatives Through Experiment and Molecular Modeling
M. Mahmoudzadeh (2015)
10.1007/BF02976689
Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats
H. Zhang (2003)
Molecular dynamics simulations and free energy calculations of netropsin and distamycin binding to anAAAAADNA binding site
J Dolenc (2005)
10.1007/S00894-004-0187-8
Characterization of molecular structures and properties of polyurethanes using molecular dynamics simulations
Jarmila Repáková (2004)
A (2012) Nanotechnologies: a strategy to overcome blood-brain barrier
G De Rosa (2012)
10.2217/nnm.09.29
Brain targeting PBCA nanoparticles and the blood-brain barrier.
B. Wilson (2009)
10.1016/j.bbr.2009.12.044
The history of the cholinergic hypothesis
A. Contestabile (2011)
10.1016/j.ejps.2012.11.010
A simple molecular modeling method for the characterization of polymeric drug carriers.
Miroslava Macháčková (2013)
10.1016/j.jmgm.2012.11.004
Replica exchange molecular dynamics simulation of chitosan for drug delivery system based on carbon nanotube.
C. Rungnim (2013)
10.1016/J.CARBON.2009.06.040
A molecular dynamics study of the Gibbs free energy of solvation of fullerene particles in octanol and water
Patrick S. Redmill (2009)
10.1016/j.neuropharm.2013.07.004
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand (2014)
10.1186/1471-2202-9-S3-S4
Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
G. Silva (2008)
Bioorganic & Medicinal Chemistry Nanoparticles in cellular drug delivery
AH Faraji (2009)
10.18203/2349-3259.IJCT20161408
In silico clinical trials: how computer simulation will transform the biomedical industry
M. Viceconti (2016)
[Radius of gyration is indicator of compactness of protein structure].
M. Lobanov (2008)



Semantic Scholar Logo Some data provided by SemanticScholar